 |
|
Ribavirin Therapy of Adult Respiratory Syncytial Virus Pneumonitis
R. Bruce Aylward, MD;
David R. Burdge, MD, FRCPC
Arch Intern Med. 1991;151(11):2303-2304.
Abstract
Respiratory syncytial virus is a common respiratory tract pathogen in infants. Pulmonary infection in adult and elderly populations can occur with severe and even fatal pneumonitis having been reported in several recent out-breaks. We present a previously healthy adult patient who developed respiratory syncytial virus pneumonia severe enough to require mechanical ventilation. Antiviral therapy with aerosolized ribavirin was successfully undertaken and the patient recovered completely. Respiratory syncytial virus infection should be considered in the differential diagnosis of atypical adult pneumonias. Aerosolized ribavirin therapy may be beneficial in treatment.
(Arch Intern Med. 1991;151:2303-2304)
Author Affiliations
From the Department of Internal Medicine (Dr Aylward) and Division of Infectious Disease, Department of Medicine (Dr Burdge), University Hospital—Shaughnessy Site, University of British Columbia, Vancouver.
Footnotes
Accepted for publication February 15, 1991.
Reprints are not available.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
RFI-641, a Potent Respiratory Syncytial Virus Inhibitor
Huntley et al.
Antimicrob. Agents Chemother. 2002;46:841-847.
ABSTRACT
| FULL TEXT
Respiratory Syncytial Virus
Ng et al.
NEJM 2001;345:1132-1133.
FULL TEXT
Treatment and Prevention of RSV Bronchiolitis
Dominguez
Journal of Pharmacy Practice 2001;14:166-180.
ABSTRACT
Development of Inhalational Agents for Oncologic Use
Sharma et al.
JCO 2001;19:1839-1847.
ABSTRACT
| FULL TEXT
Respiratory syncytial virus infection in a cardiac surgery intensive care unit
Feldman et al.
J. Thorac. Cardiovasc. Surg. 1994;108:1152-1152.
FULL TEXT
|
